These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1391529)
21. Effect of various oxygenation conditions and fluosol-DA on cancer chemotherapeutic agents. Teicher BA; McIntosh-Lowe NL; Rose CM Biomater Artif Cells Artif Organs; 1988; 16(1-3):533-46. PubMed ID: 2460166 [TBL] [Abstract][Full Text] [Related]
22. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU. Teicher BA; Herman TS; Rose CM Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321 [TBL] [Abstract][Full Text] [Related]
23. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo. Kim GE; Song CW Cancer Chemother Pharmacol; 1989; 25(2):99-102. PubMed ID: 2513138 [TBL] [Abstract][Full Text] [Related]
24. Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy. Teicher BA Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1109-20. PubMed ID: 7849913 [TBL] [Abstract][Full Text] [Related]
25. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy. Holden SA; Teicher BA; McIntosh NL; Rose CM Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174 [TBL] [Abstract][Full Text] [Related]
26. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation. Thomas C; Lartigau E; Malaise EP; Guichard M Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1157-60. PubMed ID: 2497094 [TBL] [Abstract][Full Text] [Related]
27. Potentiation of rat brain tumor therapy by fluosol and carbogen. Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732 [TBL] [Abstract][Full Text] [Related]
28. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation. Moulder JE; Fish BL Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322 [TBL] [Abstract][Full Text] [Related]
29. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas. Martin DF; Porter EA; Fischer JJ; Rockwell S Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598 [TBL] [Abstract][Full Text] [Related]
30. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion. Rockwell S; Mate TP; Irvin CG; Nierenburg M Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416 [TBL] [Abstract][Full Text] [Related]
31. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. Fingar VH; Mang TS; Henderson BW Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983 [TBL] [Abstract][Full Text] [Related]
32. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy. Rockwell S; Irvin CG; Kelley M Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):913-20. PubMed ID: 3141320 [TBL] [Abstract][Full Text] [Related]
33. Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation. Teicher BA; Herman TS; Hopkins RE; Menon K Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):969-74. PubMed ID: 1917627 [TBL] [Abstract][Full Text] [Related]
34. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin. Teicher BA; Lazo JS; Merrill WW; Filderman AE; Rose CM Cancer Chemother Pharmacol; 1986; 18(3):213-8. PubMed ID: 2433068 [TBL] [Abstract][Full Text] [Related]
35. Oxygenation of human tumor xenografts in nude mice by a perfluorochemical emulsion and carbogen breathing. Teicher BA; Schwartz GN; Dupuis NP; Kusomoto T; Liu M; Liu F; Northey D Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1369-75. PubMed ID: 7849946 [TBL] [Abstract][Full Text] [Related]
36. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing. Teicher BA; Holden SA; Rose CM Int J Cancer; 1985 Nov; 36(5):585-9. PubMed ID: 3932225 [TBL] [Abstract][Full Text] [Related]
37. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation. Holden SA; Herman TS; Teicher BA Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698 [TBL] [Abstract][Full Text] [Related]
38. Response of subpopulations of the FSall C fibrosarcoma to low dose x-rays and various potential enhancing agents. Tanaka J; Holden SA; Herman TS; Teicher BA Anticancer Res; 1992; 12(3):1029-33. PubMed ID: 1622113 [TBL] [Abstract][Full Text] [Related]
39. Perfluorochemical emulsions can increase tumor radiosensitivity. Teicher BA; Rose CM Science; 1984 Mar; 223(4639):934-6. PubMed ID: 6695191 [TBL] [Abstract][Full Text] [Related]
40. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumour radiosensitivity. Thomas C; Riess J; Guichard M Int J Radiat Biol; 1991 Feb; 59(2):433-45. PubMed ID: 1671693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]